as on November 5, 2025 at 2:29 am IST
Day's Low
Day's High
1.82%
Downside
0.13%
Upside
52 Week's Low
52 Week's High
22.59%
Downside
23.24%
Upside
Check Biontech Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$25.0B
EPS (TTM)
-4.1874
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.43%
PE Ratio (TTM)
-40.18
Industry PE ratio
19.200384615384614
PEG Ratio
0.0449
EBITDA
-493.7M
Revenue (TTM)
2.9B
Profit Margin
-11.98%
Return On Equity TTM
-1.84%
Track how Biontech Se P/E has moved over time to understand its valuation trends.
Biontech Se in the last 5 years
Lowest (-69.14x)
June 30, 2025
Today (-40.18x)
November 5, 2025
Industry (19.20x)
November 5, 2025
Highest (26.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -40.18x
Compare market cap, revenue, PE, and other key metrics of Biontech Se with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $25.0B | 13.95% | -40.18 | -11.98% | |
| BUY | $39.0B | 433.32% | -16.34 | -264.83% | |
| BUY | $57.3B | 207.17% | 1446.9 | 1.36% | |
| BUY | $109.2B | 92.12% | 30.3 | 31.86% | |
| BUY | $67.5B | 6.66% | 15.38 | 32.13% |
The Biontech Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biontech Se investment value today
Current value as on today
₹1,00,169
Returns
₹169
(+0.17%)
Returns from Biontech Se Stock
Dollar Returns*
₹5,648 (+5.65%)
Based on 24 analysts
54.17%
Buy
37.50%
Hold
8.33%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Biontech Se. Average target price of $133.75
Get share price movements and forecasts by analysts on Biontech Se.
What analysts predicted
21.58%UPSIDE
Target Price
$133.75
Current Price
$104.89
Analyzed by
24 Analysts
Target
$133.75
Biontech Se target price $133.75, a slight upside of 21.58% compared to current price of $104.89. According to 24 analysts rating.
Search interest for Biontech Se Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 November
Mon, 05:16 PM
-BioNTech raises 2025 revenue guidance to €2.6-2.8 billion after initial payments from Bristol Myers Squibb for cancer immunotherapy.
Mon, 05:53 PM
-BioNTech reports Q3 2025 revenues of €1.5 billion but incurs a net loss of €28.7 million amid rising R&D costs.
Tue, 00:55 AM
-Morgan Stanley raises BioNTech price target to $134, maintaining an Overweight rating after strong Q3 revenue performance.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
BioNTech SE has shown an improvement in its net profit over the last two quarters. The net profit increased from -$415.8 million to -$386.6 million, reflecting an average increase of 7.6% per quarter.
Revenue Rich
![]()
Biontech SE has shown strong performance in its revenue over the last two quarters. Revenue increased from $182.8 million to $260.8 million, indicating an average growth of 29.9% per quarter.
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 923.2% return, outperforming this stock by 955.8%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 168.7% return, outperforming this stock by 175.0%
Price Dip
![]()
In the last 3 years, BNTX stock has moved down by -32.6%
| Organisation | Biontech Se |
| Headquarters | An der Goldgrube 12, Mainz, Germany, 55131 |
| Industry | Health Technology |
| CEO | Dr. Ugur Sahin M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Sierk Poetting Ph.D. | MD, COO & Member of Management Board |
Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal & Business Officer and Member of the Management Board |
Mr. Ramon Zapata-Gomez | CFO & Member of Management Board |
Ms. Lisa Birringer | Senior Vice President of Global Financial Reporting & Accounting |
Ms. Beate Berns | Senior Vice President of Global Human Resources |
Dr. Oliver Henning Ph.D. | Senior Vice President of Operations |
Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board |
Ms. Annemarie Hanekamp | Chief Commercial Officer & Member of Management Board |
Dr. Sebastian Kreiter M.D. | Senior Vice President of Immunotherapy & Preclinical Research |
Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board |
Biontech Se share price today is $104.89 as on at the close of the market. Biontech Se share today touched a day high of $105.03 and a low of $102.98.
Biontech Se share touched a 52 week high of $129.27 on and a 52 week low of $81.2 on . Biontech Se stock price today i.e. is closed at $104.89,which is 18.86% down from its 52 week high and 29.17% up from its 52 week low.
Biontech Se market capitalisation is $0.02T as on .
Indian investors can start investing in Biontech Se (BNTX) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Biontech Se stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biontech Se share’s latest price of $104.89 as on November 5, 2025 at 2:29 am IST, you will get 0.0953 shares of Biontech Se. Learn more about
fractional shares .
Biontech Se stock has given 13.95% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?